These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 30798260)

  • 1. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
    Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; AlBloushi AF; Alzubaidi A; Gikandi PW; Stefánsson E
    Acta Ophthalmol; 2024 Sep; 102(6):720-727. PubMed ID: 38470990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunosuppressive therapy on oxygen saturation and diameter of retinal vessels in initial onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Alotaibi MD; Gikandi PW; Stefánsson E
    Acta Ophthalmol; 2021 Feb; 99(1):75-82. PubMed ID: 32592327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pretreatment indocyanine green angiography in the acute uveitic phase of Vogt-Koyanagi-Harada disease.
    Tobaigy MF; Abouammoh MA; AlBloushi AF; Saifaldein AA; Gikandi P; Almousa AN; Herbort CP; El-Asrar AA
    Acta Ophthalmol; 2024 Aug; 102(5):e679-e686. PubMed ID: 38131519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
    Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
    Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
    Lee EK; Lee SY; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
    Abu El-Asrar AM; Al Mudhaiyan T; Al Najashi AA; Hemachandran S; Hariz R; Mousa A; Al-Muammar A
    Ocul Immunol Inflamm; 2017 Aug; 25(4):475-485. PubMed ID: 27003480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute uveitic phase of Vogt-Koyanagi-Harada disease: optic nerve head swelling, ocular blood flow and retinal oxygen metabolism.
    Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Alzubaidi A; Stefánsson E
    Eye (Lond); 2023 May; 37(7):1432-1438. PubMed ID: 35768722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases.
    Usui Y; Goto H; Sakai J; Takeuchi M; Usui M; Rao NA
    Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1127-32. PubMed ID: 19308440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
    Nakai K; Gomi F; Ikuno Y; Yasuno Y; Nouchi T; Ohguro N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1089-95. PubMed ID: 22240936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial.
    Acharya NR; Rathinam SR; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Gonzales JA; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Arellanes-Garcia L; Coyne A; Porco TC; Shantha JG;
    Am J Ophthalmol; 2024 Nov; 267():100-111. PubMed ID: 38909740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
    Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
    Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
    Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
    BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic window of opportunity in the acute uveitic phase of Vogt-Koyanagi-Harada disease: Prevention of late autoimmune complications by early intervention.
    Abu El-Asrar AM; Al Rashed FA; AlBloushi AF; Tobaigy MF; Gikandi PW; Herbort CP; Opdenakker G
    Acta Ophthalmol; 2023 Mar; 101(2):e236-e245. PubMed ID: 36128841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal oximetry and systemic arterial oxygen levels.
    Eliasdottir TS
    Acta Ophthalmol; 2018 Nov; 96 Suppl A113():1-44. PubMed ID: 30460761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of choroidal blood flow velocity between initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy.
    Abu El-Asrar AM; AlBloushi AF; Abouammoh MA; Alzubaidi A; Gikandi PW; Al Faran A; Al-Kharashi AS; Al-Dahmash S
    Eye (Lond); 2024 May; 38(7):1269-1275. PubMed ID: 38129662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.